Tellimer

AU : HRL Holdings - Activity continuing to improve

HRL delivered a positive 3Q21 trading update underpinned by solid performances across its core Analytica and HAZMAT businesses. The recovery in environmental testing activity was a highlight and should support an ongoing improvement in margins as volumes continue to grow over FY22/23F. With underlying activity levels increasing, HRL confirmed it was comfortable with consensus FY21 underlying EBITDA of ~A$7.3m. We sit largely in line with consensus and leave our forecasts unchanged for now. With a solid medium-term growth outlook and M&A potential, ADD maintained.


Most Viewed See latest
Disclosures

This publication is being distributed by Tellimer solely for information purposes irrespective of a particular user's means, financial situation or investment objectives. The information does not con...

Full Tellimer disclaimers